E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI)
Applied Radiology · 2026-07 · 1 (5) · 1-3
DOI: 10.37549/jpcr-26-0104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Radiology, 2026-07. Verfasst von Brandon D. Timmerman und 3 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
E-cigarette or vaping product use-associated lung injury is a serious and potentially life-threatening respiratory condition characterized by diffuse lung injury following recent use of vaping or e-cigarette products. Patients commonly present with nonspecific respiratory symptoms such as cough, chest pain, and dyspnea, along with constitutional symptoms, including fever, chills, fatigue, weakness, and malaise. A small number of pediatric patients may present with isolated gastrointestinal symptoms. Noncontrast chest CT is the preferred imaging modality and may show a range of findings consistent with diffuse lung injury. Treatment is primarily supportive and may include supplemental oxygen, empiric antibiotics, and systemic glucocorticoids based on clinical presentation.
Zitieren
APA
Timmerman, B. D., Towbin, R. B., Schaefer, C. M., & Towbin, A. J. (2026). E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI). Applied Radiology, 1(5), 1-3. https://doi.org/10.37549/jpcr-26-0104
Vancouver
Timmerman BD, Towbin RB, Schaefer CM, Towbin AJ. E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI). Applied Radiology. 2026;1(5):1-3. doi:10.37549/jpcr-26-0104
BibTeX
@article{Timmerman2026,
author = {Timmerman, Brandon D. and Towbin, Richard B. and Schaefer, Carrie M. and Towbin, Alexander J.},
title = {E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI)},
journal = {Applied Radiology},
year = {2026},
volume = {1},
number = {5},
pages = {1--3},
doi = {10.37549/jpcr-26-0104}
}
EUVIMED